Contact information
Simon Kerridge
Senior Quality Assurance Manager
Simon Kerridge has worked as the Senior Quality Assurance Manager for STRONG within the University of Oxford since May 2024, where he develops and maintains core systems to ensure research is conducted in compliance with Good Clinical Practice and regulatory requirements. Prior to moving to STRONG, Simon developed the quality systems and QA team at Oxford Vaccine Centre, including leading the QA activity during the development of the Oxford-AstraZeneca COVID-19 vaccine.
Recent publications
-
The Impact of Infant Bacille Calmette-Guérin Vaccination on the Immunogenicity of Other Vaccines: A Randomized Exploratory Study.
Maytum A. et al, (2024), Pediatr Infect Dis J
-
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
-
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Flaxman A. et al, (2021), Lancet, 398, 981 - 990